Karim Chamie - Concepedia

Author

Karim Chamie

University of California, Los Angeles

Also Known As

K Chamie, K. Chamie, Karim Chamie, Litwin, Mark S., Lotan Y., Trinity J. Bivalacqua

301

Publications

7.5K

Citations

H-Index

Concepts

All Affiliations

University of California, Los Angeles UCLA Jonsson Comprehensive Cancer Center The University of Texas MD Anderson Cancer Center UCLA Medical Center University of California, Davis

About

Karim Chamie is an author at University of California, Los Angeles specializing in medicine, oncology, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	44	1.7K
2	Health Sciences	5	5	171
3	Public Health	5	5	198
4	Clinical Immunology	3	3	84
5	Cell Biology	1	1	37

Karim Chamie

Publications

4.7K

Citations

H-Index

Page 1

	Year	Citations
Recurrence of high‐risk bladder cancer: A population‐based analysis Karim Chamie, Mark S. Litwin, Jeffrey C. Bassett, Cancer	2013	363
Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008 Nicholas M. Donin, Christopher P. Filson, Alexandra Drakaki, Cancer	2016	338
An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non–muscle-invasive bladder cancer: Interim results Vignesh T. Packiam, Donald L. Lamm, Daniel A. Barocas, Urologic Oncology Seminars and Original Investigations UrologyOpen LabelGenitourinary CancerMedicineCancer Management	2017	231
Histopathology of Surgically Treated Renal Cell Carcinoma: Survival Differences by Subtype and Stage Kirk A. Keegan, Clayton W. Schupp, Karim Chamie, The Journal of Urology	2012	197
Compliance with guidelines for patients with bladder cancer Karim Chamie, Christopher S. Saigal, Julie Lai, Cancer	2011	150
Overtreatment of men with low‐risk prostate cancer and significant comorbidity Timothy J. Daskivich, Karim Chamie, Lorna Kwan, Cancer	2010	146
Nuclear versus Cytoplasmic Localization of Filamin A in Prostate Cancer: Immunohistochemical Correlation with Metastases Roble Bedolla, Yu Wang, Alfredo Asuncion, Clinical Cancer Research	2009	137
IL-15 Superagonist NAI in BCG-Unresponsive Non–Muscle-Invasive Bladder Cancer Karim Chamie, Sam S. Chang, Eugene V. Kramolowsky, NEJM Evidence	2022	136
Adjuvant Weekly Girentuximab Following Nephrectomy for High-Risk Renal Cell Carcinoma Karim Chamie, Nicholas M. Donin, Pia Klöpfer, JAMA Oncology	2016	134
Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial Nir Kleinmann, Surena F. Matin, Phillip M. Pierorazio, The Lancet Oncology UrologySurgical OncologyMalignant DiseaseGenitourinary CancerMedicine	2020	128

Page 1